Hudson Executive Capital LP View Ray, Inc. Transaction History

Hudson Executive Capital LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$3.45 - $5.83 $784,771 - $1.33 Million	227,470 Added 1.47%	15,752,093 $61.7 Million
Q4 2021 Feb 14, 2022	BUY	$4.89 - $7.59 $3.67 Million - $5.69 Million	749,939 Added 5.08%	15,524,623 $85.5 Million
Q1 2021 May 17, 2021	BUY	$4.03 - $7.25 $7.05 Million - $12.7 Million	1,750,000 Added 13.44%	14,774,684 $64.3 Million
Q1 2020 May 15, 2020	BUY	$1.35 - $4.05 $17.6 Million - $52.7 Million	13,024,684 New	13,024,684 $32.6 Million

645K

50K

30K

Ticker VRAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 181,010,000
Market Cap $1.81M
Description
ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin tox...

Get notified when there are updates to the investment portfolio of Hudson Executive Capital LP, based on Form 13F filings with the SEC.

Stay updated on Hudson Executive Capital LP with notifications on news.